Profile
Martin J.
Hughes worked as a Director of Quality, Regulatory & Clinical Affairs at Myconostica Ltd.
and as a Senior Scientist at Microscience Ltd.
He also worked as a Principal at F2G Ltd.
from 2002 to 2009.
Hughes earned a doctorate degree from The University of Nottingham in 1991.
Former positions of Martin J. Hughes
Companies | Position | End |
---|---|---|
Microscience Ltd.
Microscience Ltd. Pharmaceuticals: MajorHealth Technology Microscience is an emerging vaccine company which is primarily involved in the discovery and development of innovative, rationally designed vaccines and immunotherapeutics for the prevention and treatment of disease in areas that the Company believes to represent a significant opportunity for new vaccines | Corporate Officer/Principal | - |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Corporate Officer/Principal | - |
Myconostica Ltd.
Myconostica Ltd. Electronic Equipment/InstrumentsElectronic Technology Myconostica Ltd. developed molecular diagnostic fungal testing kits. The company was founded in February 2006 and is headquartered in Cambridge, the United Kingdom. | Chief Tech/Sci/R&D Officer | - |
Training of Martin J. Hughes
The University of Nottingham | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Myconostica Ltd.
Myconostica Ltd. Electronic Equipment/InstrumentsElectronic Technology Myconostica Ltd. developed molecular diagnostic fungal testing kits. The company was founded in February 2006 and is headquartered in Cambridge, the United Kingdom. | Electronic Technology |
Microscience Ltd.
Microscience Ltd. Pharmaceuticals: MajorHealth Technology Microscience is an emerging vaccine company which is primarily involved in the discovery and development of innovative, rationally designed vaccines and immunotherapeutics for the prevention and treatment of disease in areas that the Company believes to represent a significant opportunity for new vaccines | Health Technology |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Martin J. Hughes